Engaging Patients in Real-World Evidence: An Atrial Fibrillation Patient Advisory Board Case Example

被引：0
|
作者：
Elisabeth M. Oehrlein
Xuemei Luo
Mirko Savone
Trudie Lobban
Amiee Kang
Brian Lee
Rex Gale
Silke Schoch
Eleanor Perfetto
机构：
[1] National Health Council,Department Pharmaceutical Health Services Research
[2] Pfizer,undefined
[3] Inc,undefined
[4] Health Economics and Outcomes Research,undefined
[5] Pfizer,undefined
[6] Inc.,undefined
[7] Heart Rhythm Alliance,undefined
[8] Arrhythmia Alliance,undefined
[9] Bristol-Myers Squibb Company,undefined
[10] Board Member-Arrhythmia Alliance,undefined
[11] University of Maryland Baltimore,undefined
来源：
The Patient - Patient-Centered Outcomes Research | 2021年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：295 / 300
页数：5
相关论文
共 50 条
  • [1] Engaging Patients in Real-World Evidence: An Atrial Fibrillation Patient Advisory Board Case Example
    Oehrlein, Elisabeth M.
    Luo, Xuemei
    Savone, Mirko
    Lobban, Trudie
    Kang, Amiee
    Lee, Brian
    Gale, Rex
    Schoch, Silke
    Perfetto, Eleanor
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2021, 14 (02): : 295 - 300
  • [2] Edoxaban Anticoagulation in Atrial Fibrillation: Real-World Data and Evidence
    Cay, Serkan
    Kasap, Mithat
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2023, 51 (08): : 565 - 573
  • [3] Rivaroxaban and apixaban in patients with atrial fibrillation; a real-world data
    Aslan, Onur
    Yildirim, Sinan
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (04) : 948 - 957
  • [4] Real-world variability in dabigatran levels in patients with atrial fibrillation
    Chan, N. C.
    Coppens, M.
    Hirsh, J.
    Ginsberg, J. S.
    Weitz, J. I.
    Vanassche, T.
    Douketis, J. D.
    Schulman, S.
    Eikelboom, J. W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (03) : 353 - 359
  • [5] Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
    Lin, Shin-Yi
    Kuo, Ching-Hua
    Yeh, Shin-Joe
    Tsai, Li-Kai
    Liu, Yen-Bin
    Huang, Chih-Fen
    Tang, Sung-Chun
    Jeng, Jiann-Shing
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (01) : 278 - 286
  • [6] Rivaroxaban Precision Dosing Strategy for Real-World Atrial Fibrillation Patients
    Konicki, Robyn
    Weiner, Daniel
    Herbert Patterson, J.
    Gonzalez, Daniel
    Kashuba, Angela
    Cao, Yanguang Carter
    Gehi, Anil K.
    Watkins, Paul
    Powell, J. Robert
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (04): : 777 - 784
  • [7] Real-world performance of the atrial fibrillation monitor in patients with a subcutaneous ICD
    Baalman, Sarah W. E.
    Mittal, Suneet
    Boersma, Lucas V. A.
    Perschbacher, Dave
    Brisben, Amy J.
    Mahajan, Deepa
    Groot, Joris R.
    Knops, Reinoud E.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2020, 43 (12): : 1467 - 1475
  • [8] Ischaemic stroke and bleeding rates in 'real-world' atrial fibrillation patients
    Ogilvie, Isla M.
    Welner, Sharon A.
    Cowell, Warren
    Lip, Gregory Y. H.
    THROMBOSIS AND HAEMOSTASIS, 2011, 106 (01) : 34 - 44
  • [9] Real-world variability in dabigatran levels in patients with atrial fibrillation: comment
    Douxfils, J.
    Chatelain, B.
    Dogne, J. -M.
    Mullier, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (06) : 1166 - 1168
  • [10] Real-world variability in dabigatran levels in patients with atrial fibrillation: reply
    Chan, N. C.
    Hirsh, J.
    Ginsberg, J. S.
    Eikelboom, J. W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (06) : 1168 - 1169
12345